Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib and Palbociclib in KRAS/NRAS Mutant Metastatic Colorectal Cancer
NCT03981614Phase 2Completed
- Sponsor
- Academic and Community Cancer Research United
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of binimetinib and palbociclib in colorectal cancer (CRC), sponsored by Academic and Community Cancer Research United. Started Oct 2019; status: completed.
02
Drugs
binimetinibpalbociclib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03981614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03981614.